Hasil Pencarian - Claudio Denzlinger
- Menampilkan 1 - 3 hasil dari 3
-
1
Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group oleh Frédéric Baron, Stefan Suciu, Sergio Amadori, Petra Muus, Heinz Zwierzina, Claudio Denzlinger, Michel Delforge, Antoine Thyss, Dominik Selleslag, Karel Indrak, Gert Ossenkoppele, Theo de Witte
Diterbitkan 2012-04-01
Artikel -
2
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial oleh Annika Kurreck, Volker Heinemann, Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, Florian Kaiser, Jens Uhlig, Michael Schenk, Jens Freiberg-Richter, Bettina Peuser, Claudio Denzlinger, Ullrich Graeven, Kathrin Heinrich, Swantje Held, Arndt Stahler, Annabel Helga Sophie Alig, Ivan Jelas, Jobst C. von Einem, Sebastian Stintzing, Clemens Giessen-Jung, Dominik P. Modest
Diterbitkan 2022-02-01
Artikel -
3
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia oleh Annika Nelde, Annika Nelde, Annika Nelde, Yacine Maringer, Yacine Maringer, Yacine Maringer, Tatjana Bilich, Tatjana Bilich, Tatjana Bilich, Helmut R. Salih, Helmut R. Salih, Malte Roerden, Malte Roerden, Malte Roerden, Jonas S. Heitmann, Jonas S. Heitmann, Ana Marcu, Jens Bauer, Jens Bauer, Marian C. Neidert, Claudio Denzlinger, Gerald Illerhaus, Walter Erich Aulitzky, Hans-Georg Rammensee, Hans-Georg Rammensee, Hans-Georg Rammensee, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz
Diterbitkan 2021-07-01
Artikel